Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Szigetvar – page 24

461 clinical trials in Szigetvar, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.

Szigetvar at a glance
461
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

461 trials in Szigetvar

Open in trial search

Study on the Effectiveness and Safety of VRDN-003 for Patients with Chronic Thyroid Eye Disease

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:VRDN-003
  • Sponsor:Viridian Therapeutics Inc.

Study Comparing EYP-1901 and Aflibercept for Patients with Wet Age-Related Macular Degeneration

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Eyepoint Inc.

Asthma

Not recruiting

Study on Tozorakimab for Adults with Uncontrolled Asthma Using Medium-to-High Dose Inhaled Corticosteroids

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol Sulfate
  • Sponsor:Astrazeneca AB

Systemic scleroderma

Not recruiting

Study on the Effectiveness and Safety of Efgartigimod PH20 SC for Adults with Systemic Sclerosis

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Multiple sclerosis

Not recruiting

Study on the Effectiveness and Safety of Frexalimab and Teriflunomide for Adults with Relapsing Multiple Sclerosis

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Neurodermatitis

Not recruiting

Study on Dupilumab for Itch Relief in Adults with Lichen Simplex Chronicus (Neurodermatitis)

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Dupilumab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study Comparing Elacestrant and Standard Endocrine Therapy for Patients with Early Breast Cancer at High Risk of Recurrence

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Stemline Therapeutics Inc.

Study on Sotagliflozin for Improving Symptoms in Patients with Hypertrophic Cardiomyopathy

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Sotagliflozin
  • Sponsor:Lexicon Pharmaceuticals Inc.

Study on the Safety and Effectiveness of Inclisiran for Children Aged 6 to Under 12 with Familial Hypercholesterolemia

Registered drug
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Inclisiran
  • Sponsor:Novartis Pharma AG

Study on the Effectiveness and Safety of ANX007 Injections for Patients with Geographic Atrophy from Age-Related Macular Degeneration

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:ANX007
  • Sponsor:Annexon Inc.

Uveitis+1

Not recruiting

Study on the Effects of Brepocitinib and Prednisone for Adults with Active Non-Infectious Uveitis

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Prednisone
  • Sponsor:Priovant Therapeutics Inc.

Neurodermatitis

Not recruiting

Study on the Effectiveness of Dupilumab Injections for Itch Relief in Adults with Lichen Simplex Chronicus

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Dupilumab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Other cities in Hungary

The busiest research cities in the country

All 73 cities in Hungary

Clinical research in Szigetvar

What the registry says about research in the country

01 Respiratory Medicine

Comprehensive research focusing on severe asthma treatments, particularly in pediatric populations. Studies evaluate novel therapies including dupilumab and tezepelumab for improving respiratory function.

  • Pediatric Asthma Management
  • Severe Exacerbation Prevention
  • Respiratory Function Improvement

Multiple trials are exploring innovative approaches to control asthma symptoms in children aged 2-12 years.

02 Allergic Conditions

Investigations into allergic rhinoconjunctivitis treatments, with specific focus on birch pollen allergies. Research includes evaluation of STALORAL® Birch therapy for pediatric and adolescent patients.

  • Allergy Immunotherapy
  • Pediatric Allergy Treatment
  • Symptom Management

Studies aim to improve quality of life for young patients with seasonal allergies.

03 Cardiovascular Research

Advanced studies in heart failure prevention and cardiovascular health, including investigation of baxdrostat in combination with dapagliflozin. Additional focus on cardiovascular complications in dialysis patients.

  • Heart Failure Prevention
  • Cardiovascular Risk Management
  • ESKD-related Heart Disease

Research targets reduction of cardiovascular events and mortality in high-risk populations.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.